Compare Jumia Technologies AG - ADR (JMIA) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jumia Technologies AG - ADR vs Summit Therapeutics Inc — how do they compare? Jumia Technologies AG - ADR trades at $6.35 (market cap $783.99M), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Summit Therapeutics Inc is far larger — about 13.4× Jumia Technologies AG - ADR's market cap. Which is the better fit depends on your goals.
| JMIA | SMMT | |
|---|---|---|
Market Cap | $783.99M | $10.48B |
Sector | Consumer Cyclical | Health |
52-Week High | $14.60 | $29.32 |
52-Week Low | $4.45 | $13.05 |
Enterprise Value | $731.09M | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
